MSL3

MSL3 is a chromatin-reader subunit of the MSL dosage compensation complex that couples recognition of active-chromatin histone marks to spreading of the complex and H4K16 acetylation along the X chromosome (PMID:21217699, PMID:19029895). Its N-terminal chromo-barrel domain engages methylated histone tails through a four-residue aromatic cage, binding H4K20me1/me2 and co-recognizing DNA, while H4K16 acetylation antagonizes this engagement, providing a modification-sensitive switch for complex spreading (PMID:20657587, PMID:20943666); the same domain confers preferential affinity for H3K36me3 nucleosomes and is required for the second targeting step that moves the complex from chromatin entry sites into transcribed gene bodies (PMID:19029895). The C-terminal MRG domain docks onto the MSL1 scaffold, and this contact both targets MSL3 to the X-chromosomal territory and activates MOF's nucleosomal H4K16 acetyltransferase activity, with X-targeting and transcriptional activation being functionally separable activities of the protein (PMID:21217699, PMID:15988010, PMID:16547465). MSL3 is itself acetylated by MOF at a single lysine adjacent to its chromodomain and deacetylated by the RPD3 complex, an acetylation-deacetylation cycle that tunes roX2 RNA binding and X-chromosomal localization (PMID:12769850). Beyond canonical dosage compensation, MSL3 reads H3K36me3 independently of the complex to promote ATAC-dependent transcription during Drosophila germline stem cell differentiation (PMID:34878097). Pathogenic human MSL3 variants disrupt complex assembly, reduce bulk H4K16ac, and cause the Basilicata-Akhtar neurodevelopmental syndrome, with HDAC inhibition partially rebalancing acetylation in patient cells (PMID:30224647).

1. 1999 Low

   Establishing a human ortholog of Drosophila MSL-3 was the first step toward asking whether dosage-compensation machinery is conserved in humans.

   Evidence database homology search and genomic mapping of MSL3L1 to Xp22.3

   PMID:10395802

   Open questions at the time

   • computational identification only; no functional experiments on the human protein
   • chromo-domain binding specificity not tested
   • complex membership not demonstrated
2. 2003 High

   Identifying MSL-3 as an acetylation substrate of MOF revealed that the reader is itself regulated by a writer-eraser cycle controlling its RNA binding and X localization.

   Evidence RNAi of DCC components, MS mapping of the acetylation site, RPD3 co-IP, and roX2 RNA-binding/localization assays in Drosophila

   PMID:12769850

   Open questions at the time

   • structural basis of how acetylation alters roX2 binding not resolved
   • in vivo kinetics of the acetylation-deacetylation cycle unknown
3. 2005 High

   Mapping the MRG domain as the MSL1-binding module showed how MSL3 is physically integrated into the complex and stimulates MOF catalysis, separating assembly from nucleic-acid binding.

   Evidence domain deletion analysis, in vitro nucleosomal HAT assays, and immunofluorescence localization in Drosophila cells

   PMID:15988010

   Open questions at the time

   • atomic detail of the MRG-MSL1 interface not yet defined here
   • mechanism of MOF activation by the interaction not resolved
4. 2006 Medium

   Demonstrating that X-chromosome targeting (MRG) and transcriptional upregulation (chromo-barrel/polar region) are separable activities clarified that MSL3 contributes two distinct functions to dosage compensation.

   Evidence domain truncation mutants assayed by immunofluorescence, RT-PCR, and viability in Drosophila

   PMID:16547465

   Open questions at the time

   • single-lab domain-separation result
   • molecular basis of the polar region's contribution to activation unknown
5. 2008 High

   Assigning the chromodomain to the spreading step distinguished chromatin entry from propagation, showing the reader drives movement into H3K36me3-marked gene bodies.

   Evidence ChIP-chip of chromodomain mutants and in vitro H3K36me3 nucleosome-binding assays in Drosophila

   PMID:19029895

   Open questions at the time

   • relative contribution of H3K36me3 versus H4K20 marks to spreading not disentangled
   • structural basis of H3K36me3 recognition not solved here
6. 2010 High

   Atomic structures of the chromo-barrel domain defined the aromatic cage and showed dual recognition of DNA and methylated H4K20, with H4K16ac acting as an antagonistic switch.

   Evidence ternary MSL3 chromodomain-DNA-H4K20me1 crystal structure, human MSL3 chromo-barrel structure, peptide-binding assays, and Drosophila viability rescue with cage mutants

   PMID:20657587 PMID:20943666

   Open questions at the time

   • in vivo hierarchy among H4K20me1/me2 and H3K36me3 as the operative spreading mark unresolved
   • how H4K16ac antagonism is integrated with productive acetylation during spreading not defined
7. 2011 High

   Crystal structures of MSL1 binary complexes established MSL1 as the scaffold that recruits both MSL3 and MOF, defining the assembly architecture required for targeting gene bodies.

   Evidence X-ray structures of MSL1-MSL3 and MSL1-MOF complexes with point mutagenesis and ChIP in Drosophila

   PMID:21217699

   Open questions at the time

   • full quaternary architecture with roX RNA not resolved
   • how scaffold contacts couple to MOF catalytic activation not fully defined
8. 2018 High

   Linking pathogenic human MSL3 variants to disrupted complex assembly, reduced H4K16ac, and a neurodevelopmental syndrome translated the Drosophila mechanism into human disease and a candidate therapeutic axis.

   Evidence patient-derived cells with H4K16ac western blot, MSL complex co-IP, RNA-seq, and HDAC inhibitor rescue

   PMID:30224647

   Open questions at the time

   • tissue- and neuron-specific consequences in patients not defined
   • long-term efficacy of HDAC inhibition not established
9. 2022 Medium

   Showing a complex-independent role for Msl3 in reading H3K36me3 with ATAC during germline differentiation expanded its function beyond canonical X dosage compensation.

   Evidence genetic epistasis (msl3, set2, ATAC), RNA-seq, ribosome profiling, and immunofluorescence in Drosophila ovaries

   PMID:34878097

   Open questions at the time

   • single-lab study in one tissue
   • direct biochemical demonstration of Msl3-ATAC association not shown
10. 2023 Medium

    A negative result in mouse spermatogonia showed that MSL3 chromodomain function is dispensable for meiotic entry in rodents, indicating the germline role is not conserved as in flies.

    Evidence Stra8-iCre conditional chromodomain-disrupting knockout with histology and single-cell RNA-seq in mouse

    PMID:37847071

    Open questions at the time

    • non-chromodomain MSL3 functions in mouse germline not tested
    • compensatory redundancy not excluded

• How chromatin-mark reading, MSL3 autoacetylation, roX RNA binding, and MOF activation are integrated in real time to direct complex spreading remains unresolved.
• no integrated dynamic model coupling mark recognition to acetylation output
• human MSL3 mechanism characterized mainly through disease variants rather than reconstitution
• structural basis of full complex-RNA assembly not solved